Search

Background: Identification of infrequent nonpulmonary vein trigger premature atrial contractions (PACs) is challenging. We hypothesized that pace mapping (PM) assessed by correlation scores calculated by an intracardiac pattern matching (ICPM) module was useful for locating PAC origins, and conducted a validation study to assess the accuracy of ICPM‐guided PM. Methods: Analyzed were 30 patients with atrial fibrillation. After pulmonary vein isolation, atrial pacing was performed at one or two of four sites on the anterior and posterior aspects of the left atrium (LA, n = 10/10), LA septum (n = 10), and lateral RA (n = 10), which was arbitrarily determined as PAC. The intracardiac activation obtained from each pacing was set as an ICPM reference consisting of six CS unipolar electrograms (CS group) or six CS unipolar electrograms and four RA electrograms (CS–RA group). Results: The PM was performed at 193 ± 107 sites for each reference pacing site. All reference pacing sites corresponded to sites where the maximal ICPM correlation score was obtained. Sites with a correlation score ≥98% were rarely obtained in the CS‐RA than CS group (33% vs. 55%, P =.04), but those ≥95% were similarly obtained between the two groups (93% vs. 88%, P =.71), and those ≥90% were obtained in all. The surface areas with correlation scores ≥98% (0[0,10] vs. 10[0,35] mm2, P =.02), ≥95% (10[10,30] vs. 50[10,180] mm2, P =.002) and ≥90% (60[30,100] vs. 170[100,560] mm2, P =.0002) were smaller in the CS‐RA than CS group. Conclusions: ICPM‐guided PM was useful for identifying the reference pacing sites. Combined use of RA and CS electrograms may improve the mapping quality. [ABSTRACT FROM AUTHOR]

The article present case study of a 52-year-old woman who had been previously diagnosed with type-A Wolff-Parkinson-White (WPW) syndrome. Topics include the diagnostic assessment of a narrow QRS tachycardia; differential diagnosis between orthodromic reciprocating tachycardia (ORT) and atrioventricular nodal reentrant tachycardia (AVNRT); and the complexities in distinguishing a posteroseptal atrioventricular pathway from a rare nodoventricular pathway.

Background: The effects of the patient's disease awareness on the management of postablation of atrial fibrillation (AF) are unknown. Methods: One hundred thirty‐three AF patients undergoing an initial ablation were given a disease awareness questionnaire with a score of 16 points (8 points about AF in general and 8 points about oral anticoagulants) for the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ) before and 1‐year‐after ablation. We divided them into the poor disease awareness group and good disease awareness group according to the median value (75%) of the total JAKQ score about AF in general, and compared the baseline patient characteristics and the 1‐year changes in the JAKQ score, medication adherence, blood pressure, laboratory data, echocardiographic parameters, and AF/atrial tachycardia (AT) recurrence rate between the two groups. Results: Forty‐two (31.6%) patients were classified as having poor disease awareness (<75% of the total JAKQ score), which was closely associated with poor medication adherence, hypertension, diabetes, dyslipidemia, and greater left atrial volume (LAV). These trends in the poor disease awareness group remained unchanged 1 year after the ablation. During the 25.3‐month follow‐up, the AF/AT recurrence rate was significantly higher in the poor disease awareness than the good disease awareness group (23.8% vs. 7.7%; p =.003 by the log‐rank test). Conclusions: Poor disease awareness was linked to poor medication adherence, lifestyle‐related diseases, and greater LAV before and even 1 year after the ablation, making it a potential surrogate marker for AF/AT recurrence. These findings highlight the clinical significance of disease awareness in AF management. [ABSTRACT FROM AUTHOR]

Background and Aim: Catheter ablation (CA) of idiopathic ventricular arrhythmias (VAs) from the epicardial left ventricular summit is challenging. The endocardial approach targets two sites: the endocardial closest site (ECS) to the epicardial earliest activation site (epi-EAS) and the endocardial EAS (endo-EAS). We aimed to differentiate between cases where CA at the ECS was effective and where CA at the endocardial EAS yielded success., Methods: Fifty-eight patients (47 men, 60±13 years) were analyzed with VAs in which the EAS was observed in the coronary venous system (CVS)., Results: Overall, VAs were successfully eliminated in 42 (72%) patients; 8 in the CVS, 8 where the ECS matched with the endo-EAS, 11 at the ECS, and 15 at the endo-EAS. Successful ECS ablation was associated with a shorter epi-EAS-ECS distance (10.2±4.7 vs. 18.8±5.3 mm; P<0.001) and shorter epi-EAS-left main coronary trunk (LMT) ostial distance (20.3±7.6 vs. 30.3±8.4 mm; P=0.005), with optimal cut-off values of ≤12.6 mm and ≤24.0 mm, respectively. Successful endo-EAS ablation was associated with an earlier electrogram at the endo-EAS (23 [18, 36] vs. 15 [0, 19] ms preceding the QRS; P<0.001) and shorter epi-EAS-endo-EAS interval (6 [1, 8] vs. 22 [12, 25] ms; P<0.001), with optimal cut-off values of ≥18 ms and ≤9 ms, respectively., Conclusion: Shorter anatomical distances between the epi-EAS and ECS, and between the epi-EAS and LMT ostium, predict a successful ECS ablation. The prematurity of the endo-EAS electrogram and a shorter interval between the epi-EAS and endo-EAS predicted a successful endo-EAS ablation., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)